United States Healthcare Providers & Services

Magellan Health Inc (MGLN)

Track

Track

Ticker: MGLN Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Kamal Mostafa CEO, Magellan Rx Management Officer
Transaction date
Sale
Price
214.04
Quantity 97,208 +33.3%
Value US$4,274,137
Kamal Mostafa CEO, Magellan Rx Management Officer
Transaction date
Sale
Price
241.78
Quantity 95,249 +14.7%
Value US$3,423,540
Kamal Mostafa CEO, Magellan Rx Management Officer
Transaction date
Sale
Price
415.68
Quantity 75,667 +25.1%
Value US$3,152,651
Kamal Mostafa CEO, Magellan Rx Management Officer
Transaction date
Sale
Price
81.57
Quantity 6,000 -51.6%
Value US$489,420
Kamal Mostafa CEO, Magellan Rx Management Officer
Transaction date
Sale
Price
79.87
Quantity 3,589 -39.0%
Value US$286,653
Kamal Mostafa CEO, Magellan Rx Management Officer
Transaction date
Sale
Price
79.89
Quantity 3,434 -37.9%
Value US$274,351
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
80.00
Quantity 139 -0.6%
Value US$11,120
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
80.00
Quantity 2,481 -9.7%
Value US$198,481
Kamal Mostafa CEO, Magellan Rx Management Officer
Transaction date
Sale
Price
79.87
Quantity 183 -3.2%
Value US$14,616
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
78.50
Quantity 1,500 -6.1%
Value US$117,753
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
78.50
Quantity 4,778 -17.2%
Value US$375,094
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
78.51
Quantity 14,637 -38.9%
Value US$1,149,110
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
78.50
Quantity 1,415 -5.8%
Value US$111,078
0.8
MURRAY JAMES E President and COO Officer
Transaction date
Purchase
Price
67.63
Quantity 4,500 +inf%
Value US$304,317
WEST JEFFREY N SVP & Controller
Transaction date
Sale
Price
78.53
Quantity 200 -1.0%
Value US$15,706
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
78.50
Quantity 104 -0.5%
Value US$8,164
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
78.54
Quantity 606 -2.9%
Value US$47,597
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
78.52
Quantity 1,923 -8.7%
Value US$150,987
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
78.54
Quantity 6,114 -23.3%
Value US$480,166
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
78.62
Quantity 5,735 -22.1%
Value US$450,886
Kamal Mostafa CEO, Magellan Rx Management Officer
Transaction date
Sale
Price
78.72
Quantity 16,766 -85.7%
Value US$1,319,742
SMITH BARRY M Chief Executive Officer Executive Director
Transaction date
Sale
Price
95.86
Quantity 13,375 -30.5%
Value US$1,282,061
SMITH BARRY M Chief Executive Officer Executive Director
Transaction date
Sale
Price
92.21
Quantity 13,375 -30.5%
Value US$1,233,326
SMITH BARRY M Chief Executive Officer Executive Director
Transaction date
Sale
Price
86.02
Quantity 13,375 -23.2%
Value US$1,150,576
Kamal Mostafa CEO, Magellan Rx Management Officer
Transaction date
Sale
Price
106.20
Quantity 1,666 -100.0%
Value US$176,929
SMITH BARRY M Chief Executive Officer Executive Director
Transaction date
Sale
Price
103.52
Quantity 13,375 -23.2%
Value US$1,384,583
Kamal Mostafa CEO, Magellan Rx Management
Transaction date
Sale
Price
99.04
Quantity 15,428 -100.0%
Value US$1,527,968
GREGOIRE DANIEL N General Counsel and Secretary
Transaction date
Sale
Price
99.05
Quantity 22,875 -63.0%
Value US$2,265,698
SMITH BARRY M Chief Executive Officer Executive Director
Transaction date
Sale
Price
101.20
Quantity 13,375 -31.2%
Value US$1,353,496
SMITH BARRY M Chief Executive Officer Executive Director
Transaction date
Sale
Price
99.20
Quantity 13,375 -31.2%
Value US$1,326,765
Rubin Jonathan N Chief Financial Officer Officer
Transaction date
Sale
Price
96.16
Quantity 30,086 -53.2%
Value US$2,893,028
SMITH BARRY M Chief Executive Officer Executive Director
Transaction date
Sale
Price
95.94
Quantity 13,367 -31.2%
Value US$1,282,429
Rubin Jonathan N Chief Financial Officer Officer
Transaction date
Sale
Price
96.07
Quantity 17,443 -39.7%
Value US$1,675,782
Kamal Mostafa CEO, Magellan Rx Management
Transaction date
Sale
Price
92.00
Quantity 2,180 -100.0%
Value US$200,560
Lewis Clapper Caskie Chief Human Resources Officer
Transaction date
Sale
Price
93.99
Quantity 59,313 -76.3%
Value US$5,574,586
GREGOIRE DANIEL N General Counsel and Secretary
Transaction date
Sale
Price
89.08
Quantity 8,275 -38.1%
Value US$737,137
GREGOIRE DANIEL N General Counsel and Secretary
Transaction date
Planned sale
Price
89.20
Quantity 9,369 -41.0%
Value US$835,751
Kamal Mostafa CEO, Magellan Rx Management
Transaction date
Planned sale
Price
92.00
Quantity 1,154 -100.0%
Value US$106,168
GREGOIRE DANIEL N General Counsel and Secretary Officer
Transaction date
Sale
Price
88.10
Quantity 2,475 -15.5%
Value US$218,048
GREGOIRE DANIEL N General Counsel and Secretary Officer
Transaction date
Sale
Price
88.00
Quantity 5,000 -23.9%
Value US$440,000
GREGOIRE DANIEL N General Counsel and Secretary Officer
Transaction date
Sale
Price
88.00
Quantity 5,000 -27.1%
Value US$440,000
WEST JEFFREY N SVP & Controller
Transaction date
Sale
Price
87.31
Quantity 30,021 -68.3%
Value US$2,621,242
WEST JEFFREY N SVP & Controller
Transaction date
Sale
Price
86.22
Quantity 19,007 -57.7%
Value US$1,638,689
WEST JEFFREY N SVP & Controller
Transaction date
Sale
Price
86.18
Quantity 18,511 -57.1%
Value US$1,595,317
Kamal Mostafa CEO, Magellan Rx Management
Transaction date
Sale
Price
85.76
Quantity 4,848 -100.0%
Value US$415,782
WEST JEFFREY N SVP & Controller
Transaction date
Sale
Price
85.85
Quantity 25,316 -64.5%
Value US$2,173,452
WEST JEFFREY N SVP & Controller
Transaction date
Sale
Price
86.06
Quantity 1,419 -9.2%
Value US$122,125
WEST JEFFREY N SVP & Controller
Transaction date
Sale
Price
85.24
Quantity 18,502 -54.7%
Value US$1,577,131
GREGOIRE DANIEL N General Counsel and Secretary
Transaction date
Sale
Price
85.17
Quantity 35,658 -72.6%
Value US$3,036,928
Kamal Mostafa CEO, Magellan Rx Management
Transaction date
Sale
Price
86.06
Quantity 600 -100.0%
Value US$51,635
Kamal Mostafa CEO, Magellan Rx Management
Transaction date
Sale
Price
85.31
Quantity 18,526 -96.9%
Value US$1,580,373
GREGOIRE DANIEL N General Counsel and Secretary
Transaction date
Sale
Price
83.00
Quantity 2,402 -15.1%
Value US$199,366
Kamal Mostafa CEO, Magellan Rx Management
Transaction date
Sale
Price
84.00
Quantity 2,961 -100.0%
Value US$248,724
GREGOIRE DANIEL N General Counsel and Secretary
Transaction date
Sale
Price
83.05
Quantity 18,063 -57.3%
Value US$1,500,163
Kamal Mostafa CEO, Magellan Rx Management
Transaction date
Sale
Price
83.00
Quantity 585 -100.0%
Value US$48,555
GREGOIRE DANIEL N General Counsel and Secretary
Transaction date
Sale
Price
83.06
Quantity 14,096 -51.2%
Value US$1,170,883
Kamal Mostafa CEO, Magellan Rx Management
Transaction date
Sale
Price
83.00
Quantity 19 -100.0%
Value US$1,577
Kamal Mostafa CEO, Magellan Rx Management
Transaction date
Sale
Price
83.00
Quantity 670 -100.0%
Value US$55,610
GREGOIRE DANIEL N General Counsel and Secretary
Transaction date
Sale
Price
83.00
Quantity 2,400 -15.1%
Value US$199,200
Kamal Mostafa CEO, Magellan Rx Management
Transaction date
Sale
Price
81.53
Quantity 6,267 -100.0%
Value US$510,918
Kamal Mostafa CEO, Magellan Rx Management
Transaction date
Sale
Price
81.19
Quantity 1,033 -100.0%
Value US$83,870
Kamal Mostafa CEO, Magellan Rx Management
Transaction date
Sale
Price
80.96
Quantity 1,157 -100.0%
Value US$93,669
GREGOIRE DANIEL N General Counsel and Secretary Officer
Transaction date
Sale
Price
80.68
Quantity 4,559 -25.3%
Value US$367,820
GREGOIRE DANIEL N General Counsel and Secretary Officer
Transaction date
Sale
Price
80.12
Quantity 32,398 -70.7%
Value US$2,595,582
GREGOIRE DANIEL N General Counsel and Secretary Officer
Transaction date
Sale
Price
80.02
Quantity 1,176 -8.0%
Value US$94,102
GREGOIRE DANIEL N General Counsel and Secretary Officer
Transaction date
Sale
Price
80.06
Quantity 16,073 -54.4%
Value US$1,286,751
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
80.01
Quantity 1,109 -7.4%
Value US$88,728
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
80.10
Quantity 600 -4.1%
Value US$48,060
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
80.07
Quantity 27,914 -66.7%
Value US$2,234,940
GREGOIRE DANIEL N General Counsel and Secretary Officer
Transaction date
Sale
Price
80.11
Quantity 14,114 -51.2%
Value US$1,130,685
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
82.10
Quantity 100 -0.9%
Value US$8,210
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
81.05
Quantity 100 -0.9%
Value US$8,105
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
80.00
Quantity 100 -0.9%
Value US$8,000
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
81.12
Quantity 300 -2.5%
Value US$24,335
WEST JEFFREY N SVP & Controller Officer
Transaction date
Sale
Price
80.28
Quantity 12,912 -51.9%
Value US$1,036,516
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-12-11 2020-12-09 S Sale
Kamal Mostafa

CEO, Magellan Rx Management

Officer
97,208 +33.3%
214.04
US$4,274,137 		97,208 +33.3% 214.04 US$4,274,137
2020-11-17 2020-11-16 S Sale
Kamal Mostafa

CEO, Magellan Rx Management

Officer
95,249 +14.7%
241.78
US$3,423,540 		95,249 +14.7% 241.78 US$3,423,540
2020-11-17 2020-11-13 S Sale
Kamal Mostafa

CEO, Magellan Rx Management

Officer
75,667 +25.1%
415.68
US$3,152,651 		75,667 +25.1% 415.68 US$3,152,651
2020-11-12 2020-11-10 S Sale
Kamal Mostafa

CEO, Magellan Rx Management

Officer
6,000 -51.6%
81.57
US$489,420 		6,000 -51.6% 81.57 US$489,420
2020-11-06 2020-11-05 S Sale
Kamal Mostafa

CEO, Magellan Rx Management

Officer
3,589 -39.0%
79.87
US$286,653 		3,589 -39.0% 79.87 US$286,653
2020-11-06 2020-11-04 S Sale
Kamal Mostafa

CEO, Magellan Rx Management

Officer
3,434 -37.9%
79.89
US$274,351 		3,434 -37.9% 79.89 US$274,351
2020-11-06 2020-11-04 S Sale
WEST JEFFREY N

SVP & Controller

Officer
139 -0.6%
80.00
US$11,120 		139 -0.6% 80.00 US$11,120
2020-11-06 2020-11-04 S Sale
WEST JEFFREY N

SVP & Controller

Officer
2,481 -9.7%
80.00
US$198,481 		2,481 -9.7% 80.00 US$198,481
2020-10-20 2020-10-16 S Sale
Kamal Mostafa

CEO, Magellan Rx Management

Officer
183 -3.2%
79.87
US$14,616 		183 -3.2% 79.87 US$14,616
2020-10-07 2020-10-07 S Sale
WEST JEFFREY N

SVP & Controller

Officer
1,500 -6.1%
78.50
US$117,753 		1,500 -6.1% 78.50 US$117,753
2020-10-07 2020-10-06 S Sale
WEST JEFFREY N

SVP & Controller

Officer
4,778 -17.2%
78.50
US$375,094 		4,778 -17.2% 78.50 US$375,094
2020-10-07 2020-10-05 S Sale
WEST JEFFREY N

SVP & Controller

Officer
14,637 -38.9%
78.51
US$1,149,110 		14,637 -38.9% 78.51 US$1,149,110
2020-06-10 2020-06-08 S Sale
WEST JEFFREY N

SVP & Controller

Officer
1,415 -5.8%
78.50
US$111,078 		1,415 -5.8% 78.50 US$111,078
2020-05-19 2020-05-15 B Purchase
0.8
MURRAY JAMES E

President and COO

Officer
4,500 +inf%
67.63
US$304,317 		4,500 +inf% 67.63 US$304,317
2020-01-03 2020-01-02 S Sale
WEST JEFFREY N

SVP & Controller
200 -1.0%
78.53
US$15,706 		200 -1.0% 78.53 US$15,706
2019-12-31 2019-12-30 S Sale WEST JEFFREY N

SVP & Controller

Officer
104 -0.5%
78.50
US$8,164 		104 -0.5% 78.50 US$8,164
2019-12-30 2019-12-27 S Sale WEST JEFFREY N

SVP & Controller

Officer
606 -2.9%
78.54
US$47,597 		606 -2.9% 78.54 US$47,597
2019-12-27 2019-12-26 S Sale WEST JEFFREY N

SVP & Controller

Officer
1,923 -8.7%
78.52
US$150,987 		1,923 -8.7% 78.52 US$150,987
2019-12-26 2019-12-24 S Sale WEST JEFFREY N

SVP & Controller

Officer
6,114 -23.3%
78.54
US$480,166 		6,114 -23.3% 78.54 US$480,166
2019-12-17 2019-12-16 S Sale WEST JEFFREY N

SVP & Controller

Officer
5,735 -22.1%
78.62
US$450,886 		5,735 -22.1% 78.62 US$450,886
2019-12-11 2019-12-09 S Sale Kamal Mostafa

CEO, Magellan Rx Management

Officer
16,766 -85.7%
78.72
US$1,319,742 		16,766 -85.7% 78.72 US$1,319,742
2018-07-03 2018-07-02 S Sale SMITH BARRY M

Chief Executive Officer

Executive Director
13,375 -30.5%
95.86
US$1,282,061 		13,375 -30.5% 95.86 US$1,282,061
2018-06-04 2018-06-01 S Sale SMITH BARRY M

Chief Executive Officer

Executive Director
13,375 -30.5%
92.21
US$1,233,326 		13,375 -30.5% 92.21 US$1,233,326
2018-05-02 2018-05-01 S Sale SMITH BARRY M

Chief Executive Officer

Executive Director
13,375 -23.2%
86.02
US$1,150,576 		13,375 -23.2% 86.02 US$1,150,576
2018-04-04 2018-04-02 S Sale Kamal Mostafa

CEO, Magellan Rx Management

Officer
1,666 -100.0%
106.20
US$176,929 		1,666 -100.0% 106.20 US$176,929
2018-04-04 2018-04-02 S Sale SMITH BARRY M

Chief Executive Officer

Executive Director
13,375 -23.2%
103.52
US$1,384,583 		13,375 -23.2% 103.52 US$1,384,583
2018-03-06 2018-03-05 S Sale Kamal Mostafa

CEO, Magellan Rx Management
15,428 -100.0%
99.04
US$1,527,968 		15,428 -100.0% 99.04 US$1,527,968
2018-03-06 2018-03-05 S Sale GREGOIRE DANIEL N

General Counsel and Secretary
22,875 -63.0%
99.05
US$2,265,698 		22,875 -63.0% 99.05 US$2,265,698
2018-03-02 2018-03-01 S Sale SMITH BARRY M

Chief Executive Officer

Executive Director
13,375 -31.2%
101.20
US$1,353,496 		13,375 -31.2% 101.20 US$1,353,496
2018-02-02 2018-02-01 S Sale SMITH BARRY M

Chief Executive Officer

Executive Director
13,375 -31.2%
99.20
US$1,326,765 		13,375 -31.2% 99.20 US$1,326,765
2018-01-04 2018-01-03 S Sale Rubin Jonathan N

Chief Financial Officer

Officer
30,086 -53.2%
96.16
US$2,893,028 		30,086 -53.2% 96.16 US$2,893,028
2018-01-03 2018-01-02 S Sale SMITH BARRY M

Chief Executive Officer

Executive Director
13,367 -31.2%
95.94
US$1,282,429 		13,367 -31.2% 95.94 US$1,282,429
2018-01-03 2018-01-02 S Sale Rubin Jonathan N

Chief Financial Officer

Officer
17,443 -39.7%
96.07
US$1,675,782 		17,443 -39.7% 96.07 US$1,675,782
2017-12-06 2017-12-04 S Sale Kamal Mostafa

CEO, Magellan Rx Management
2,180 -100.0%
92.00
US$200,560 		2,180 -100.0% 92.00 US$200,560
2017-12-05 2017-12-04 S Sale Lewis Clapper Caskie

Chief Human Resources Officer
59,313 -76.3%
93.99
US$5,574,586 		59,313 -76.3% 93.99 US$5,574,586
2017-12-04 2017-12-01 S Sale GREGOIRE DANIEL N

General Counsel and Secretary
8,275 -38.1%
89.08
US$737,137 		8,275 -38.1% 89.08 US$737,137
2017-11-02 2017-11-01 PlS Planned sale GREGOIRE DANIEL N

General Counsel and Secretary
9,369 -41.0%
89.20
US$835,751 		9,369 -41.0% 89.20 US$835,751
2017-11-02 2017-11-01 PlS Planned sale Kamal Mostafa

CEO, Magellan Rx Management
1,154 -100.0%
92.00
US$106,168 		1,154 -100.0% 92.00 US$106,168
2017-10-05 2017-10-04 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
2,475 -15.5%
88.10
US$218,048 		2,475 -15.5% 88.10 US$218,048
2017-10-05 2017-10-04 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
5,000 -23.9%
88.00
US$440,000 		5,000 -23.9% 88.00 US$440,000
2017-10-05 2017-10-03 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
5,000 -27.1%
88.00
US$440,000 		5,000 -27.1% 88.00 US$440,000
2017-10-04 2017-10-03 S Sale WEST JEFFREY N

SVP & Controller
30,021 -68.3%
87.31
US$2,621,242 		30,021 -68.3% 87.31 US$2,621,242
2017-10-03 2017-10-02 S Sale WEST JEFFREY N

SVP & Controller
19,007 -57.7%
86.22
US$1,638,689 		19,007 -57.7% 86.22 US$1,638,689
2017-10-03 2017-09-29 S Sale WEST JEFFREY N

SVP & Controller
18,511 -57.1%
86.18
US$1,595,317 		18,511 -57.1% 86.18 US$1,595,317
2017-09-29 2017-09-28 S Sale Kamal Mostafa

CEO, Magellan Rx Management
4,848 -100.0%
85.76
US$415,782 		4,848 -100.0% 85.76 US$415,782
2017-09-29 2017-09-28 S Sale WEST JEFFREY N

SVP & Controller
25,316 -64.5%
85.85
US$2,173,452 		25,316 -64.5% 85.85 US$2,173,452
2017-09-29 2017-09-27 S Sale WEST JEFFREY N

SVP & Controller
1,419 -9.2%
86.06
US$122,125 		1,419 -9.2% 86.06 US$122,125
2017-09-29 2017-09-27 S Sale WEST JEFFREY N

SVP & Controller
18,502 -54.7%
85.24
US$1,577,131 		18,502 -54.7% 85.24 US$1,577,131
2017-09-28 2017-09-27 S Sale GREGOIRE DANIEL N

General Counsel and Secretary
35,658 -72.6%
85.17
US$3,036,928 		35,658 -72.6% 85.17 US$3,036,928
2017-09-28 2017-09-27 S Sale Kamal Mostafa

CEO, Magellan Rx Management
600 -100.0%
86.06
US$51,635 		600 -100.0% 86.06 US$51,635
2017-09-28 2017-09-27 S Sale Kamal Mostafa

CEO, Magellan Rx Management
18,526 -96.9%
85.31
US$1,580,373 		18,526 -96.9% 85.31 US$1,580,373
2017-09-18 2017-09-15 S Sale GREGOIRE DANIEL N

General Counsel and Secretary
2,402 -15.1%
83.00
US$199,366 		2,402 -15.1% 83.00 US$199,366
2017-09-18 2017-09-15 S Sale Kamal Mostafa

CEO, Magellan Rx Management
2,961 -100.0%
84.00
US$248,724 		2,961 -100.0% 84.00 US$248,724
2017-09-18 2017-09-14 S Sale GREGOIRE DANIEL N

General Counsel and Secretary
18,063 -57.3%
83.05
US$1,500,163 		18,063 -57.3% 83.05 US$1,500,163
2017-09-14 2017-09-13 S Sale Kamal Mostafa

CEO, Magellan Rx Management
585 -100.0%
83.00
US$48,555 		585 -100.0% 83.00 US$48,555
2017-09-14 2017-09-13 S Sale GREGOIRE DANIEL N

General Counsel and Secretary
14,096 -51.2%
83.06
US$1,170,883 		14,096 -51.2% 83.06 US$1,170,883
2017-09-14 2017-09-12 S Sale Kamal Mostafa

CEO, Magellan Rx Management
19 -100.0%
83.00
US$1,577 		19 -100.0% 83.00 US$1,577
2017-09-12 2017-09-11 S Sale Kamal Mostafa

CEO, Magellan Rx Management
670 -100.0%
83.00
US$55,610 		670 -100.0% 83.00 US$55,610
2017-09-12 2017-09-11 S Sale GREGOIRE DANIEL N

General Counsel and Secretary
2,400 -15.1%
83.00
US$199,200 		2,400 -15.1% 83.00 US$199,200
2017-09-11 2017-09-08 S Sale Kamal Mostafa

CEO, Magellan Rx Management
6,267 -100.0%
81.53
US$510,918 		6,267 -100.0% 81.53 US$510,918
2017-09-08 2017-09-07 S Sale Kamal Mostafa

CEO, Magellan Rx Management
1,033 -100.0%
81.19
US$83,870 		1,033 -100.0% 81.19 US$83,870
2017-09-08 2017-09-05 S Sale Kamal Mostafa

CEO, Magellan Rx Management
1,157 -100.0%
80.96
US$93,669 		1,157 -100.0% 80.96 US$93,669
2017-07-26 2017-07-25 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
4,559 -25.3%
80.68
US$367,820 		4,559 -25.3% 80.68 US$367,820
2017-07-25 2017-07-24 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
32,398 -70.7%
80.12
US$2,595,582 		32,398 -70.7% 80.12 US$2,595,582
2017-07-25 2017-07-21 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
1,176 -8.0%
80.02
US$94,102 		1,176 -8.0% 80.02 US$94,102
2017-07-21 2017-07-20 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
16,073 -54.4%
80.06
US$1,286,751 		16,073 -54.4% 80.06 US$1,286,751
2017-07-21 2017-07-20 S Sale WEST JEFFREY N

SVP & Controller

Officer
1,109 -7.4%
80.01
US$88,728 		1,109 -7.4% 80.01 US$88,728
2017-07-18 2017-07-17 S Sale WEST JEFFREY N

SVP & Controller

Officer
600 -4.1%
80.10
US$48,060 		600 -4.1% 80.10 US$48,060
2017-07-18 2017-07-14 S Sale WEST JEFFREY N

SVP & Controller

Officer
27,914 -66.7%
80.07
US$2,234,940 		27,914 -66.7% 80.07 US$2,234,940
2017-07-17 2017-07-14 S Sale GREGOIRE DANIEL N

General Counsel and Secretary

Officer
14,114 -51.2%
80.11
US$1,130,685 		14,114 -51.2% 80.11 US$1,130,685
2017-02-27 2017-02-24 S Sale WEST JEFFREY N

SVP & Controller

Officer
100 -0.9%
82.10
US$8,210 		100 -0.9% 82.10 US$8,210
2017-02-27 2017-02-24 S Sale WEST JEFFREY N

SVP & Controller

Officer
100 -0.9%
81.05
US$8,105 		100 -0.9% 81.05 US$8,105
2017-02-27 2017-02-24 S Sale WEST JEFFREY N

SVP & Controller

Officer
100 -0.9%
80.00
US$8,000 		100 -0.9% 80.00 US$8,000
2017-02-27 2017-02-23 S Sale WEST JEFFREY N

SVP & Controller

Officer
300 -2.5%
81.12
US$24,335 		300 -2.5% 81.12 US$24,335
2017-02-27 2017-02-23 S Sale WEST JEFFREY N

SVP & Controller

Officer
12,912 -51.9%
80.28
US$1,036,516 		12,912 -51.9% 80.28 US$1,036,516
Explore more

More insider trading research around Magellan Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America